Arvee Laboratories Peer Comparison
NSE: ARVEE
₹234.50
As on 28-Sep-2026IST
Market cap
₹258 Cr
Revenue (TTM)
₹41 Cr
P/E Ratio
63.8
P/B Ratio
7.3
Div. Yield
0 %
| Arvee Laboratories | Aether | Deepak Nitrite | Aarti | Fine Organic | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
258 | 23,032 | 21,155 | 17,279 | 15,696 |
Revenue (₹ Cr) |
41 | 1,224 | 8,575 | 9,013 | 2,472 |
Net Profit (₹ Cr) |
4.05 | 235.19 | 783.41 | 531.00 | 442.47 |
Net Margin (%) |
9.65 | 18.79 | 9.08 | 5.88 | 17.20 |
RoE (%) |
12.41 | 10.03 | 13.96 | 8.95 | 17.04 |
Price to Earnings |
63.84 | 97.93 | 27.01 | 32.54 | 35.83 |
Price-To-Book |
7.28 | 9.16 | 3.42 | 2.83 | 5.60 |
Income Statement (₹ Cr)
| Arvee Laboratories | Aether | Deepak Nitrite | Aarti | Fine Organic | |
|---|---|---|---|---|---|
|
Operating Revenue
|
41.26 | 1,223.90 | 8,574.79 | 9,013.00 | 2,471.58 |
|
Total Income
|
41.95 | 1,251.61 | 8,624.11 | 9,023.00 | 2,572.69 |
|
Total Expenditure
|
35.91 | 839.85 | 7,243.44 | 7,681.00 | 1,936.26 |
|
EBITDA
|
5.35 | 384.05 | 1,331.35 | 1,332.00 | 535.32 |
|
Depreciation
|
1.24 | 73.63 | 237.05 | 484.00 | 58.44 |
|
EBIT
|
4.11 | 310.42 | 1,094.30 | 848.00 | 476.88 |
|
Interest
|
0.26 | 18.87 | 60.80 | 364.00 | 4.50 |
|
Other Income
|
0.69 | 27.71 | 49.32 | 10.00 | 101.11 |
|
Exceptional Items
|
0.00 | -6.34 | -12.84 | 8.00 | 0.00 |
|
Profit before Tax
|
4.54 | 312.91 | 1,069.98 | 502.00 | 573.49 |
|
Provision for Tax
|
0.49 | 77.72 | 286.57 | -29.00 | 131.02 |
|
Profit after Tax
|
4.05 | 235.19 | 783.41 | 531.00 | 442.47 |
Liabilities (₹ Cr)
| Arvee Laboratories | Aether | Deepak Nitrite | Aarti | Fine Organic | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
33.79 | 2,455.89 | 5,836.83 | 5,955.00 | 2,664.52 |
|
Minority Interest
|
0.00 | 0.00 | -0.15 | 0.00 | 0.00 |
|
Non-Current Liabilities
|
1.93 | 88.20 | 1,532.66 | 2,306.00 | 60.92 |
|
Current Liabilities
|
7.54 | 657.34 | 1,278.74 | 5,038.00 | 273.37 |
|
Total Liabilities
|
37.57 | -- | 7,706.02 | 11,113.52 | 2,503.77 |
Assets (₹ Cr)
| Arvee Laboratories | Aether | Deepak Nitrite | Aarti | Fine Organic | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
17.62 | 1,754.09 | 5,145.91 | 8,995.00 | 503.53 |
|
Current Assets
|
25.23 | 1,171.47 | 3,069.38 | 4,187.00 | 2,320.20 |
|
Total Assets
|
37.57 | -- | 7,706.02 | 11,113.52 | 2,503.77 |
|
Total Debt*
|
1.03 | -- | 1,170.53 | 3,789.55 | 0.00 |
|
Net Current Assets
|
17.69 | 514.14 | 1,790.64 | -851.00 | 2,046.82 |
|
Contingent Liabilities
|
-- | -- | 0.53 | 320.61 | 9.17 |
Cashflow (₹ Cr)
| Arvee Laboratories | Aether | Deepak Nitrite | Aarti | Fine Organic | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-0.21 | -- | 624.70 | 1,237.62 | 204.00 |
|
Cash Flow from Investing Activities
|
-1.32 | -- | -1,491.33 | -1,393.35 | -668.28 |
|
Cash from Financing Activities
|
-0.12 | -- | 806.16 | -73.17 | -34.67 |
|
Net Cash Inflow / Outflow
|
-1.64 | -- | -60.47 | -228.90 | -498.95 |
Ratios
Profitability Ratios
| Arvee Laboratories | Aether | Deepak Nitrite | Aarti | Fine Organic | |
|---|---|---|---|---|---|
|
ROCE (%)
|
10.00 | -- | 17.00 | 6.39 | 26.45 |
|
ROE (%)
|
12.41 | 10.03 | 13.96 | 8.95 | 17.04 |
|
ROA (%)
|
9.94 | 8.05 | 9.55 | 4.35 | 16.06 |
|
EBIT Margin (%)
|
9.95 | 25.36 | 12.76 | 9.41 | 19.29 |
|
Net Margin (%)
|
9.65 | 18.79 | 9.08 | 5.88 | 17.20 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| Arvee Laboratories | Aether | Deepak Nitrite | Aarti | Fine Organic | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
16.67 | 33.72 | 7.12 | 27.03 | 7.10 |
|
EBIT Growth (%)
|
220.70 | 34.90 | 41.57 | 85.15 | 7.32 |
|
Net Profit Growth (%)
|
194.61 | 34.01 | 29.05 | 124.05 | 6.52 |
|
EPS Growth (%)
|
194.61 | 30.29 | 30.59 | 123.11 | 7.07 |
|
Book Value Growth (%)
|
7.38 | -- | 12.34 | 5.85 | 19.59 |
Valuation Ratios
| Arvee Laboratories | Aether | Deepak Nitrite | Aarti | Fine Organic | |
|---|---|---|---|---|---|
|
Price / Earnings
|
63.84 | 95.94 | 26.69 | 33.09 | 35.83 |
|
Price / Book Value
|
7.28 | 9.16 | 3.42 | 2.83 | 5.60 |
|
Dividend Yield (%)
|
0.00 | 0.00 | 0.48 | 0.21 | 0.21 |
|
EV/EBITDA
|
47.60 | 61.11 | 16.69 | 16.21 | 26.70 |
|
Market Cap (₹ Cr)
|
156.47 | -- | 27,044.64 | 14,156.47 | 12,246.82 |
Solvency Ratios
| Arvee Laboratories | Aether | Deepak Nitrite | Aarti | Fine Organic | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.03 | 0.00 | 0.19 | 0.37 | 0.02 |
|
Short term debt to equity ratio
|
-- | -- | 0.03 | 0.30 | -- |
|
Current Ratio
|
3.35 | 1.78 | 2.40 | 0.83 | 8.49 |
|
Quick Ratio
|
2.13 | 0.96 | 1.73 | 0.49 | 7.02 |
|
Interest Coverage
|
18.67 | 17.58 | 18.60 | 2.38 | 128.53 |
Operating Efficiency Ratios
| Arvee Laboratories | Aether | Deepak Nitrite | Aarti | Fine Organic | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
25.33 | 31.87 | 17.56 | 15.57 | 14.21 |
|
Asset Turnover
|
1.01 | 0.42 | 1.05 | 0.74 | 0.90 |
|
Receivable days
|
68.81 | -- | 56.28 | 37.06 | 51.80 |
|
Inventory Days
|
51.92 | -- | 36.90 | 59.06 | 50.11 |
|
Payable days
|
87.33 | -- | 33.64 | 84.85 | 41.45 |
|
Cash Conversion Cycle
|
33.40 | -- | 59.53 | 11.27 | 60.46 |